Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 2024 Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, November 19, 2024, at 12:00 p.m. GMT (7:00 a.m. ET).

Interested parties can access a live webcast of the presentation through the Investors section of Kiniksa's website at www.kiniksa.com. A replay will be made available on the company's website within 48 hours after the event.

News Market Reaction – KNSA

-1.61%

-1.61% Session move

In the trading session that priced this news, KNSA declined 1.61%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ^®

Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com

FAQ

When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies London Healthcare Conference 2024?

Kiniksa Pharmaceuticals will present on Tuesday, November 19, 2024, at 12:00 p.m. GMT (7:00 a.m. Eastern Time).

How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast through the Investors section of Kiniksa's website at www.kiniksa.com.

Will there be a replay available of Kiniksa's (KNSA) Jefferies Conference presentation?

Yes, a replay will be available on Kiniksa's website within 48 hours after the event.

What type of presentation will Kiniksa Pharmaceuticals (KNSA) give at the Jefferies Conference?

Kiniksa's management will participate in a fireside chat format presentation.